The prevalence of proarrhythmic events during moricizine therapy and their relationship to ventricular function
- 31 October 1992
- journal article
- clinical trial
- Published by Elsevier in American Heart Journal
- Vol. 124 (4) , 912-916
- https://doi.org/10.1016/0002-8703(92)90972-x
Abstract
No abstract availableKeywords
This publication has 12 references indexed in Scilit:
- Preliminary Report: Effect of Encainide and Flecainide on Mortality in a Randomized Trial of Arrhythmia Suppression after Myocardial InfarctionNew England Journal of Medicine, 1989
- Arrhythmogenic effects of antiarrhythmic drugs: A study of 506 patients treated for ventricular tachycardia or fibrillationJournal of the American College of Cardiology, 1989
- Prevalence and characteristics of proarrhythmia from moricizine (Ethmozine®)The American Journal of Cardiology, 1989
- Clinical Characteristics of Patients with Ventricular Fibrillation during Antiarrhythmic Drug TherapyNew England Journal of Medicine, 1988
- Proarrhythmic effects of antiarrhythmic drugs in patients with malignant ventricular arrhythmias evaluated by electrophysiologic testingJournal of the American College of Cardiology, 1988
- Aggravation of arrhythmia by antiarrhythmic drugs—Incidence and predictorsThe American Journal of Cardiology, 1987
- Aggravation of arrhythmia induced with antiarrhythmic drugs during electrophysiologic testingAmerican Heart Journal, 1985
- Antiarrhythmic Drugs: a Possible Cause of Out-of-Hospital Cardiac ArrestNew England Journal of Medicine, 1983
- Long-term survival of patients with malignant ventricular arrhythmia treated with antiarrhythmic drugsThe American Journal of Cardiology, 1982
- Aggravation and provocation of ventricular arrhythmias by antiarrhythmic drugs.Circulation, 1982